CAR-Based Approaches to Cutaneous T-Cell Lymphoma

by Irene Scarfò, Irene Scarfò, Matthew J. Frigault, Matthew J. Frigault, Marcela V. Maus, Marcela V. Maus, Marcela V. Maus
Published 2019-04-01

CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma

by Bryan D. Choi, Xiaoling Yu, Ana P. Castano, Henia Darr, Daniel B. Henderson, Amanda A. Bouffard, Rebecca C. Larson, Irene Scarfò, Stefanie R. Bailey, Genevieve M. Gerhard, Matthew J. Frigault, Mark B. Leick, Andrea Schmidts, Jason G. Sagert, William T. Curry, Bob S. Carter, Marcela V. Maus
Published 2019-11-01

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events

by Frederick L Locke, Elizabeth J Shpall, Jorg Dietrich, Daniel W Lee, Matthew J Frigault, Terry J Fry, Sara Alexander, Jennifer N Brudno, Colleen Callahan, Marco L Davila, Claudia Diamonte, Julie C Fitzgerald, Jennifer L Holter-Chakrabarty, Krishna V Komanduri, Shannon L Maude, Philip L McCarthy, Elena Mead, David T Teachey, Cameron J Turtle, Tom Whitehead
Published 2020-07-01